Expanding China Healthcare And Global Pipelines Will Broaden Patient Options
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
30 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$56.15
36.4% undervalued intrinsic discount15 Aug
US$35.73
1Y
109.2%7D
2.2%